Navigation Links
Surefire Infusion System Found Safe and Effective for Delivery of 90Y in Treating Inoperable Liver Cancer
Date:7/10/2013

WESTMINSTER, Colo., July 10, 2013 /PRNewswire/ -- Case reports published in the Journal of Cardiovascular and Interventional Radiology found that by using the Surefire Infusion System, radioembolization could be successfully performed without the need to protect nearby blood vessels, a significant advance that may enable doctors to safely extend liver cancer treatment to patients who were previously deemed untreatable.

None of the three patients, including one who otherwise could not have been treated, suffered complications as a result of the minimally invasive procedure.  All were discharged the following day.

"With the protection from reflux afforded by Surefire's novel, expandable, funnel-shaped tip we performed successful yttrium-90 radioembolization without coiling," said Prof. Dr. Maurice van den Bosch, Interventional Radiologist, University Medical Center Utrecht, The Netherlands.  "Positron emission tomography-computed tomography (PET-CT) confirmed adequate, efficient biodistribution of the microspheres in targeted liver segments only."

In recent years, Interventional Oncology has emerged as a pillar of modern cancer care.  In numerous clinical studies, improved patient outcomes have been achieved with embolization therapy and systemic chemotherapy compared to systemic chemotherapy alone.

"We are gratified that our advanced technology enables a broader population of patients to be treated, including those who otherwise may not have received treatment," said Surefire Medical CEO Jim Chomas.  "These case studies add to the rapidly growing body of clinical evidence indicating that the Surefire Infusion System safely, efficiently and precisely delivers therapy.  It may contribute not only to enhanced treatment effectiveness, but also to the palliation of cancers to improve quality of life."

About Surefire Medical

Surefire Medical, Inc., based in Westminster, Colo., was founded in 2009 to develop a new class of infusion systems for the interventional radiology and interventional oncology markets.  Surefire's infusion systems are designed to precisely deliver embolic agents through a unique microcatheter with an expandable tip that collapses in forward flow and dynamically expands to the vessel wall in reverse flow in order to maximize targeted delivery, minimize reflux and reduce damage to healthy tissue.  For more information, please visit www.surefiremedical.com.


'/>"/>
SOURCE Surefire Medical
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Surefire Medical Receives FDA Clearance For High-Flow Microcatheter
2. Surefire Medicals Infusion System For Embolization Procedures Receives CE Mark Approval
3. Christopher Mennone Joins Surefire Medical Team As International Business Director
4. Surefire Medical, Inc.: Gene McGrevin Joins Surefire Medicals Board of Directors
5. Study: Surefire Medicals Technology Improves Delivery Of Embolics In Cancer Treatment
6. Surefire Infusion System Used In Potential New Hunger-Reducing Obesity Treatment -- NIH Funds Johns Hopkins Study
7. Sirtex To Distribute Surefire Medicals Innovative Infusion System in Australia and Asia Pacific Markets
8. Aperture Health, Inc. focuses in on IV Therapy Value Creation and the Merger and Acquisition Activities in the Home Infusion Therapy Sector.
9. CareFusion Expands Infusion Pump Interoperability
10. Global Infusion Pumps Market 2011-2015
11. Riordan Lewis & Haden
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... March 28, 2017  Medeon Biodesign, Inc., a ... is pleased to announce that the Company led ... Panther Orthopedics, Inc., a San Jose, ... solutions for orthopedic extremity applications.  ... rapidly, primarily due to procedure volume growth, lifestyle ...
(Date:3/28/2017)... , Va. and PHOENIX , March 28, ... Avella Specialty Pharmacy released a new white ... allergies and the use of latex in healthcare. Specifically, there ... in healthcare. In fact, the FDA has urged manufacturers to ... latex" claim from labels, because of the challenge to ensure ...
(Date:3/28/2017)... Kingdom and  BOSTON , March 28, 2017 ... Linguamatics today announced a partnership with premium ... agreement allows pharmaceutical companies to extract key insights ... text mining technology. The Linguamatics ... the top 20 global pharmaceutical companies. The Linguamatics-Dow ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... March 28, 2017 , ... ... advancing the science and clinical practice of radiosurgery, announced today the publication ... multi-institutional, observational registry established to standardize data collection from patients treated with ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... today that the University of Pittsburgh Medical Center (UPMC) will acquire QuikClot® Bleeding ... Pennsylvania. , The program, developed in association with efforts by the American College ...
(Date:3/28/2017)... ... , ... The Radiology Business Management Association (RBMA) is pleased to ... executive director. Mr. Still was selected through a careful months-long search by the RBMA ... known to our members, has been a part of building the RBMA since 1992,” ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... Wethersfield, Conn., has relocated its corporate headquarters to a new, more expansive office ... , In October 2016, Qualidigm purchased a distressed office building in Wethersfield, Conn. ...
(Date:3/28/2017)... ... March 28, 2017 , ... METTLER ... ions found in power plant water and steam. , Chlorides and sulfates cause ... boilers, leading to extensive maintenance and unplanned shutdowns. Monitoring these ions at low ...
Breaking Medicine News(10 mins):